Shivalik Rasayan Approves Q3 FY26 Un-Audited Financial Results
Shivalik Rasayan Limited's Board approved the un-audited financial results for Q3 FY26. The company reported standalone net profit of ₹203.49 Lakhs and consolidated net profit of ₹269.63 Lakhs for the quarter ended December 31, 2025. The results also cover the nine-month period ended the same date.
The approval of quarterly financial results is a material event for investors and stakeholders, impacting investment decisions and company valuation. However, the absence of significant positive or negative highlights in the announcement itself limits the immediate impact to medium.
The announcement reports the approval of financial results, which is a routine disclosure. While the results themselves may have positive or negative implications, the announcement of their approval is neutral.
Shivalik Rasayan Limited announced the outcome of its Board Meeting held on February 13, 2026. The Board approved the Un-Audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025.
The approved results include the statement of Un-Audited Financial Results, Unaudited Segment-wise Revenue, Results, Assets and Liabilities, and the Limited Review Report from Rahul Chaudhary & Associates. The meeting commenced at 4:00 p.m. and concluded at 5:10 p.m.
The financial results for the period ended December 31, 2025, will be available on the company's website, www.shivalikrasayan.com. The company operates in three business segments: Agro Chemicals, Active Pharma Ingredient (API), and Pharma Formulations.
What to do with a filing like this
Shivalik Rasayan Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shivalik Rasayan Limited. Read the original for the full detail.